Josep M. Llovet, MD is ICREA Research Professor, BCLC Group, Liver Unit, IDIBAPS, Hospital Clinic, Univ. of Barcelona, Prof. of Medicine and Director of the Liver Cancer Program at the Icahn Mount Sinai School of Medicine, NY. He has published 242 manuscripts in Liver Cancer, including NEJM, Lancet, Nature, Nat. Genetics, Cancer Cell and Gastroenterology (IF: 3262;citations: 44.256;h-index: 85). Top 1% most cited researcher globally, Thomson Reuters 2014, 2015, 2016, Educational Councilor (2013-15), President of the ILCA (2011-13), Senior Editor of CCR, he has lectured in 500 international meetings and has been the PI of European grants FP7-HEPTROMIC,HEP-CAR,NIH-NIDDK R01-award, I+D grants and competitive private grants. His achievements are: 1. Establish a clinical and molecular classification for HCC. 2. Establish efficacy of chemoembolization and sorafenib for HCC. 3. Identification of novel drivers and activated pathways in HCC and ICC.